Skip to Content

328 Results Found

  • Article
  • Open Access
17 Citations
1,400 Views
5 Pages

1 June 2007

In medicine, assigning priorities for original ideas and for first implementation of a new type of treatment or technology—radium afterloading, for example—is often difficult. This situation is certainly true for radium therapy, with conflicting clai...

  • Review
  • Open Access
5 Citations
3,387 Views
20 Pages

The Tight Relationship Between the Tumoral Microenvironment and Radium-223

  • Miriam Conte,
  • Miriam Tomaciello,
  • Maria Silvia De Feo,
  • Viviana Frantellizzi and ,
  • Francesco Marampon,
  • Flaminia De Cristofaro,
  • Giuseppe De Vincentis and
  • Luca Filippi
  • + 3 authors+ 0 author

Radium-223 (223Ra) was the first radioactive isotope approved for treating castration-resistant prostate cancer (CRPC) with symptomatic bone metastases without visceral metastatic disease. To better understand the action of 223Ra, its role in the tum...

(This article belongs to the Section Cancer Biology and Oncology)
  • Article
  • Open Access
12 Citations
5,408 Views
11 Pages

19 March 2020

Unconventional shale gas exploitation presents complex problems in terms of radioactive waste disposal. Large volumes of saline produced water resulting from hydraulic fracturing are typically enriched in radium isotopes, up to several hundred Bq/dm3...

(This article belongs to the Special Issue Barite)
  • Article
  • Open Access
1 Citations
2,392 Views
12 Pages

Association between the Immunophenotype of Peripheral Blood from mCRPC Patients and the Outcomes of Radium-223 Treatment

  • Elisabet Cantó,
  • Georgia Anguera,
  • Natalia Jiménez,
  • Begoña Mellado and ,
  • Ona Ramírez,
  • Anais Mariscal,
  • Pablo Maroto and
  • Silvia Vidal
  • + 3 authors+ 0 author

(1) Background: Prostate cancer is the second most common cancer in men, with androgen suppression as the standard treatment. Despite initially responding to castration, most metastatic prostate cancer patients eventually experience progression. In t...

(This article belongs to the Special Issue Biomarkers of Urological Disease)
  • Article
  • Open Access
10 Citations
5,509 Views
15 Pages

Enhanced Antitumor Efficacy of Radium-223 and Enzalutamide in the Intratibial LNCaP Prostate Cancer Model

  • Mari I. Suominen,
  • Matias Knuuttila,
  • Christoph A. Schatz,
  • Andreas Schlicker and ,
  • Jukka Vääräniemi,
  • Birgitta Sjöholm,
  • Esa Alhoniemi,
  • Bernard Haendler,
  • Dominik Mumberg and
  • Arne Scholz
  • + 6 authors+ 1 author

22 January 2023

Radium-223 dichloride and enzalutamide are indicated for metastatic castration-resistant prostate cancer and their combination is currently being investigated in a large phase 3 clinical trial. Here, we evaluated the antitumor efficacy of radium-223,...

(This article belongs to the Special Issue Prostate Cancer: Pathology, Pathobiology and Therapy)
  • Article
  • Open Access
782 Views
9 Pages

212Pb is an important medical radionuclide for targeted alpha therapy, and its reliable supply depends on the efficient production of parent nuclides such as 228Ra, 228Th, and 224Ra. Natural thorium resources are abundant and represent a potential so...

(This article belongs to the Section Separation Engineering)
  • Article
  • Open Access
4,484 Views
13 Pages

Clinical Outcome Patterns of Use of Radium-223 in Patients with Metastatic Castration-Resistant Prostate Cancer

  • Colleen Mackenzie,
  • Jasna Deluce,
  • Morgan Black,
  • Emma Churchman and ,
  • Eric Winquist,
  • Scott Ernst,
  • David T. Laidley,
  • Matthew Parezanovic,
  • Kylea Potvin and
  • Ricardo Fernandes
  • + 5 authors+ 0 author

22 October 2024

Introduction: Radium-223 dichloride (radium-223) is a bone-targeting radioisotope therapy that aids in the survival of patients with metastatic castration-resistant prostate cancer (mCRPC) to bones. This study aimed to describe the clinical character...

(This article belongs to the Section Genitourinary Oncology)
  • Review
  • Open Access
14 Citations
7,945 Views
30 Pages

Targeted Radium Alpha Therapy in the Era of Nanomedicine: In Vivo Results

  • György Trencsényi,
  • Csaba Csikos and
  • Zita Képes

Targeted alpha-particle therapy using radionuclides with alpha emission is a rapidly developing area in modern cancer treatment. To selectively deliver alpha-emitting isotopes to tumors, targeting vectors, including monoclonal antibodies, peptides, s...

(This article belongs to the Collection Feature Papers in Molecular Nanoscience)
  • Article
  • Open Access
4 Citations
4,806 Views
15 Pages

Additive Benefits of Radium-223 Dichloride and Bortezomib Combination in a Systemic Multiple Myeloma Mouse Model

  • Mari I. Suominen,
  • Jenni Mäki-Jouppila,
  • Anna Huhtinen,
  • Birgitta Sjöholm and ,
  • Jukka P. Rissanen,
  • Anniina Luostarinen,
  • Katja M. Fagerlund,
  • Esa Alhoniemi,
  • Gerhard Siemeister and
  • Arne Scholz
  • + 7 authors+ 2 authors

Osteolytic bone disease is a hallmark of multiple myeloma (MM) mediated by MM cell proliferation, increased osteoclast activity, and suppressed osteoblast function. The proteasome inhibitor bortezomib targets MM cells and improves bone health in MM p...

(This article belongs to the Special Issue Bone Metastasis Challenge: New Ideas and Future Perspectives)
  • Communication
  • Open Access
1,985 Views
9 Pages

Uranium and Radium in Groundwater and Incidence of Colorectal Cancer in Georgia Counties, USA: An Ecologic Study

  • Taylor Rooney,
  • Lissa Soares,
  • Tesleem Babalola,
  • Alex Kensington and ,
  • Jennie Williams and
  • Jaymie R. Meliker
  • + 1 author+ 0 author

28 September 2024

Colorectal cancer (CRC) is the third most commonly occurring cancer in the United States, with higher incidence rates among Black populations. Groundwater concentrations of natural radionuclides uranium and radium have seldom been investigated in rel...

(This article belongs to the Special Issue Health Effects of Exposure to Environmental Pollutants)
  • Article
  • Open Access
1 Citations
2,682 Views
14 Pages

Darolutamide in Combination with Radium-223 Exhibits Synergistic Antitumor Efficacy in LNCaP Prostate Cancer Models

  • Urs B. Hagemann,
  • Christoph A. Schatz,
  • Mari I. Suominen,
  • Andreas Schlicker and ,
  • Matias Knuuttila,
  • Timothy Wilson,
  • Esa Alhoniemi,
  • Sanna-Maria Käkönen,
  • Bernard Haendler and
  • Arne Scholz
  • + 5 authors+ 0 author

21 December 2024

Despite treatment, prostate cancer commonly progresses into castration-resistant prostate cancer (CRPC), which remains largely incurable, requiring the development of new interventions. Darolutamide is an orally administered second-generation androge...

(This article belongs to the Special Issue Molecular Mechanisms Underlying the Progression of Prostate Cancer)
  • Article
  • Open Access
23 Citations
3,675 Views
9 Pages

Background and Objective: Radium-223 dichloride (Xofigo®) is a calcium mimetic agent approved for the treatment of castration-resistant prostate cancer patients with symptomatic bone metastases and no known visceral metastatic disease. This targe...

  • Review
  • Open Access
4 Citations
6,374 Views
15 Pages

29 October 2024

Recent advances have broadened the range of therapeutic options for mCRPC, with several new treatments, including novel hormonal therapies (enzalutamide, abiraterone), chemotherapeutic agents (docetaxel, cabazitaxel), immunotherapies (sipuleucel-T),...

(This article belongs to the Section Medical Imaging and Theranostics)
  • Review
  • Open Access
35 Citations
8,082 Views
16 Pages

10 August 2019

Bone metastasis is a common clinical complication in several cancer types, and it causes a severe reduction in quality of life as well as lowering survival time. Bone metastases proceed through a vicious self-reinforcing cycle that can be osteolytic...

(This article belongs to the Special Issue Tumor Bone Microenvironment, Bone Turnover and Stem Cell)
  • Article
  • Open Access
4 Citations
3,359 Views
18 Pages

Zoledronic Acid Prevents Bone Resorption Caused by the Combination of Radium-223, Abiraterone Acetate, and Prednisone in an Intratibial Prostate Cancer Mouse Model

  • Mari I. Suominen,
  • Matias Knuuttila,
  • Birgitta Sjöholm,
  • Timothy Wilson and ,
  • Esa Alhoniemi,
  • Dominik Mumberg,
  • Sanna-Maria Käkönen and
  • Arne Scholz
  • + 3 authors+ 0 author

15 August 2023

An increased risk of non-pathological fractures in patients with prostate cancer and bone metastases has been associated with combination treatment with radium-223, abiraterone, and prednisone/prednisolone in the absence of bone-protecting agents. He...

(This article belongs to the Section Cancer Therapy)
  • Article
  • Open Access
6 Citations
5,604 Views
16 Pages

Utilization of Radium-Bead Material for Road Safety: An Application of the Circular Economy Concept

  • Sajid Hussain,
  • Xuemei Zhou,
  • Syyed Adnan Raheel Shah,
  • Naveed Ahmad and ,
  • Muhammad Kashif Anwar and
  • Muhammad Aamir Basheer
  • + 1 author+ 0 author

27 October 2021

Road safety has become a serious issue in both developed and developing countries, costing billions of dollars every year. Road accidents at nighttime especially in low illumination situations are common and severe and have gained a lot of attention....

(This article belongs to the Special Issue Polymers and the Circular Economy Model)
  • Article
  • Open Access
1 Citations
3,543 Views
14 Pages

Enzalutamide Prior to Radium-223 Is Associated with Better Overall Survival in Metastatic Castration-Resistant Prostate Cancer Patients Compared to Abiraterone—A Retrospective Study

  • Hao Xiang Chen,
  • Li-Hsien Tsai,
  • Chao-Hsiang Chang,
  • Hsi-Chin Wu and ,
  • Ching-Chan Lin,
  • Che-Hung Lin,
  • Chin-Chung Yeh,
  • Chi-Rei Yang,
  • Chi-Shun Lien and
  • Chi-Ping Huang
  • + 10 authors+ 5 authors

6 July 2023

Metastatic castration-resistant prostate cancer (mCRPC) is a progressive stage of prostate cancer that often spreads to the bone. Radium-223, a bone-targeting radiopharmaceutical, has been shown to improve the overall survival in mCRPC in patients wi...

(This article belongs to the Section Cancer Therapy)
  • Review
  • Open Access
25 Citations
7,683 Views
17 Pages

27 August 2021

Radium-223 dichloride ([223Ra]RaCl2; Ra-223) is a targeted alpha-emitting radiopharmaceutical which results in an overall survival and health related quality of life (HRQoL) benefit in symptomatic patients with metastatic castration resistant prostat...

(This article belongs to the Special Issue Current Management of Castration-Resistant Prostate Cancer (CRPC))
  • Article
  • Open Access
7 Citations
3,611 Views
16 Pages

Synergistic Activity of DNA Damage Response Inhibitors in Combination with Radium-223 in Prostate Cancer

  • Victoria L. Dunne,
  • Timothy C. Wright,
  • Francisco D. C. Guerra Liberal,
  • Joe M. O’Sullivan and
  • Kevin M. Prise

15 April 2024

Radium-223 (223Ra) and Lutetium-177-labelled-PSMA-617 (177Lu-PSMA) are currently the only radiopharmaceutical treatments to prolong survival for patients with metastatic-castration-resistant prostate cancer (mCRPC); however, mCRPC remains an aggressi...

(This article belongs to the Section Cancer Therapy)
  • Article
  • Open Access
11 Citations
5,415 Views
11 Pages

High Specific Activity of Radium Isotopes in Baryte from the Czech Part of the Upper Silesian Basin—An Example of Spontaneous Mine Water Treatment

  • Jakub Jirásek,
  • Dalibor Matýsek,
  • Petr Alexa,
  • Michal Osovský and ,
  • Radim Uhlář and
  • Martin Sivek
  • + 1 author+ 0 author

25 January 2020

Radium-bearing barytes (radiobarytes) have been known since the beginning of the 20th century. They are mainly found as precipitates of low-temperature hydrothermal solutions. In anthropogenic environments, they frequently occur as crusts on oil indu...

(This article belongs to the Special Issue Barite)
  • Article
  • Open Access
15 Citations
3,453 Views
10 Pages

Effect of Radium-223 on the Gut Microbiota of Prostate Cancer Patients: A Pilot Case Series Study

  • Ana Fernandes,
  • Ana Oliveira,
  • Carla Guedes,
  • Rúben Fernandes and ,
  • Raquel Soares and
  • Pedro Barata
  • + 1 author+ 0 author

16 October 2022

Radium-223 (Ra-223) is a targeted nuclear medicine therapy for castration-resistant prostate cancer with bone metastases. Its major route of elimination is the intestine. There is overwhelming evidence that the gut microbiota is altered by ionizing r...

(This article belongs to the Special Issue The Development of Metabolites from the Gut Microbiome via In Silico Strategy)
  • Article
  • Open Access
4 Citations
2,366 Views
17 Pages

Immune Modulation During Treatment with Enzalutamide Alone or with Radium-223 in Patients with Castration Resistant Prostate Cancer

  • Peter D. Zang,
  • Diane M. Da Silva,
  • Zhang-Xu Liu,
  • Shivani Kandukuri and ,
  • Denice Tsao-Wei,
  • Anishka D’Souza,
  • W. Martin Kast,
  • Sumanta K. Pal,
  • Cheryl Kefauver and
  • Tanya B. Dorff
  • + 8 authors+ 3 authors

21 May 2025

Introduction: Prostate cancer has been generally resistant to immunotherapy approaches. Radiation can be immunostimulatory, but the extent to which standard prostate cancer treatments induce immune activation has not been well described. The bone-tar...

(This article belongs to the Collection Oncology: State-of-the-Art Research in the USA)
  • Article
  • Open Access
5 Citations
5,140 Views
12 Pages

Investigation into the Optimal Strategy of Radium-223 Therapy for Metastatic Castration-Resistant Prostate Cancer

  • Yasuo Oguma,
  • Makoto Hosono,
  • Kaoru Okajima,
  • Eri Inoue and ,
  • Kiyoshi Nakamatsu,
  • Hiroshi Doi,
  • Tomohiro Matsuura,
  • Masahiro Inada,
  • Takuya Uehara and
  • Yasumasa Nishimura
  • + 10 authors+ 5 authors

1 September 2022

The optimal sequence and combination of radium-223 therapy (Ra-223) for castration-resistant prostate cancer with bone metastasis (mCRPC) remain unclear. This study aimed to explore the prognostic factors after Ra-223 administration and to determine...

  • Article
  • Open Access
1 Citations
2,386 Views
12 Pages

Radium-226 (226Ra) measurement in living organisms, such as the American oyster (Crassostrea virginica), is an analytical challenge: the matrix complexity and the extremely low Ra levels require a purification/preconcentration step prior to its quant...

(This article belongs to the Section Environmental Separations)
  • Article
  • Open Access
3,795 Views
15 Pages

Radium Isotopes and Hydrochemical Signatures of Surface Water-Groundwater Interaction in the Salt-Wedge Razdolnaya River Estuary (Sea of Japan) in the Ice-Covered Period

  • Pavel Semkin,
  • Pavel Tishchenko,
  • Alexander Charkin,
  • Galina Pavlova and ,
  • Yuri Barabanshchikov,
  • Andrey Leusov,
  • Petr Tishchenko,
  • Elena Shkirnikova and
  • Maria Shvetsova
  • + 4 authors+ 0 author

7 May 2023

The interaction of surface water and groundwater is important in the ecology of coastal basins, affecting hydrological conditions, oxygen regime, carbon, and nutrient exchange. This study demonstrates a dynamic connection between the salt-wedge regio...

(This article belongs to the Section Oceans and Coastal Zones)
  • Feature Paper
  • Article
  • Open Access
7 Citations
4,404 Views
28 Pages

11 January 2024

The Port Radium U-Cu-Ni-Co-Ag deposit in northwestern Canada is hosted within a mineral system that has generated a variety of mineralization styles from iron oxide-copper-gold to iron oxide-apatite, porphyry, skarn, and epithermal. Their genesis is...

(This article belongs to the Special Issue Footprints of Mineral Systems with IOCG, IOA and Affiliated Critical Metal Deposits: From Metasomatism to Metamorphism)
  • Article
  • Open Access
5 Citations
3,493 Views
15 Pages

Seasonal Variability of Nutrients and Radium Isotope Fluxes from Submarine Karstic Spring at the Southwest of Crimea, Black Sea

  • Illarion I. Dovhyi,
  • Ol’ga N. Kozlovskaia,
  • Nikolay A. Bezhin,
  • Iuliia G. Shibetskaia and ,
  • Aleksey I. Chepyzhenko and
  • Ivan G. Tananaev
  • + 1 author+ 0 author

13 February 2022

The groundwaters of the southwestern region of Crimea are formed on the karst plateaus of the Crimean Mountains, and a significant amount of them is discharged into the Black Sea. The Crimean Peninsula is a water-deficient region; therefore, the stud...

(This article belongs to the Section Oceans and Coastal Zones)
  • Article
  • Open Access
14 Citations
6,448 Views
31 Pages

Submarine Hydrothermal Discharge and Fluxes of Dissolved Fe and Mn, and He Isotopes at Brothers Volcano Based on Radium Isotopes

  • René Neuholz,
  • Charlotte Kleint,
  • Bernhard Schnetger,
  • Andrea Koschinsky and ,
  • Patrick Laan,
  • Rob Middag,
  • Sylvia Sander,
  • Janis Thal,
  • Andreas Türke and
  • Hans-Jürgen Brumsack
  • + 7 authors+ 2 authors

29 October 2020

Hydrothermal venting is an important transfer process of energy and elements between the Earth’s solid material and the oceans. Compared to mid-ocean-ridge hydrothermal vent fields, those at intra-oceanic island arcs are typically in shallower...

(This article belongs to the Section Mineral Deposits)
  • Article
  • Open Access
7 Citations
2,471 Views
11 Pages

Change of the Neutrophil-to-Lymphocyte Ratio during Treatment: A Potential Prognostic Biomarker in Metastatic Prostate Cancer Treated with Radium-223 Dichloride

  • Kevin Kaulanjan,
  • Johanna Dahan,
  • Cédric Charrois-Durand,
  • Fred Saad and ,
  • Laurent Brureau,
  • Guila Delouya,
  • Daniel Taussky and
  • Edouard Auclin
  • + 3 authors+ 0 author

22 September 2022

The neutrophil to lymphocyte ratio (NLR) at baseline has been shown to have prognostic value in metastatic prostate cancer. Little is known about the importance of a change in the NLR during treatment in patients treated with Radium-223 (223Ra). We i...

(This article belongs to the Special Issue Advances and Updates in Prognostic and Predictive Biomarkers of Urologic Malignancy)
  • Article
  • Open Access
41 Citations
10,124 Views
15 Pages

13 October 2015

The purpose of this study was to evaluate the outcome after Radium-223-dichloride (223RaCl2) treatment of patients with skeletal metastases of castration resistant prostate cancer using whole-body 18F-Fluoride PET/CT. Sodium 18F-fluoride [18F]-NaF PE...

(This article belongs to the Special Issue Prostate Cancer Diagnosis)
  • Article
  • Open Access
12 Citations
2,601 Views
12 Pages

Prognostic Value of 18F-Choline PET/CT in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Radium-223

  • Luca Filippi,
  • Gian Paolo Spinelli,
  • Agostino Chiaravalloti,
  • Orazio Schillaci and ,
  • Francesco Equitani and
  • Oreste Bagni
  • + 1 author+ 0 author

We aimed to investigate the role of positron emission computed tomography (PET/CT) with 18F-choline for predicting the outcome of metastatic castration-resistant prostate cancer (mCRPC) submitted to treatment with Radium-223 (223Ra-therapy). Clinical...

(This article belongs to the Section Cancer Biology and Oncology)
  • Feature Paper
  • Article
  • Open Access
10 Citations
2,839 Views
12 Pages

Prevalence and Prognostic Implications of PSA Flares during Radium-223 Treatment among Men with Metastatic Castration Resistant Prostate Cancer

  • Amanjot Sidhu,
  • Nabeeha Khan,
  • Cameron Phillips,
  • Juan Briones and ,
  • Anil Kapoor,
  • Pawel Zalewski,
  • Neil E. Fleshner,
  • Edward Chow and
  • Urban Emmenegger
  • + 4 authors+ 0 author

28 August 2023

Radium-223 (Ra233) prolongs the survival of men with symptomatic bone-predominant metastatic castration-resistant prostate cancer (mCRPC). However, prostate-specific antigen (PSA) response patterns are not closely associated with Ra223 therapy outcom...

(This article belongs to the Section Oncology)
  • Article
  • Open Access
6 Citations
5,940 Views
16 Pages

9 October 2021

Management of backwash water (BW) generated from sand filtration of groundwater naturally contaminated with iron (Fe), manganese (Mn), and radium (Ra) remains a challenge worldwide. The present study investigated the effectiveness of a low-cost clay...

(This article belongs to the Section Water Quality and Contamination)
  • Article
  • Open Access
8 Citations
2,943 Views
15 Pages

Radium-223 Treatment Produces Prolonged Suppression of Resident Osteoblasts and Decreased Bone Mineral Density in Trabecular Bone in Osteoblast Reporter Mice

  • Song-Chang Lin,
  • Guoyu Yu,
  • Paul G. Corn,
  • Jossana Damasco and ,
  • Yu-Chen Lee,
  • Jian H. Song,
  • Nora M. Navone,
  • Christopher J. Logothetis,
  • Marites P. Melancon and
  • Sue-Hwa Lin
  • + 6 authors+ 1 author

21 July 2024

Radium 223 (Ra-223) is an α-emitting bone-homing radiopharmaceutical that targets tumor-induced osteoblasts and is used to reduce bone pain and prolong overall survival in men with bone-metastatic, castrate-resistant prostate cancer. However, i...

(This article belongs to the Section Tumor Microenvironment)
  • Article
  • Open Access
2,291 Views
19 Pages

Preclinical Evaluation of Radium-223 and Immune Checkpoint Inhibitors Using an Immune-Competent Model of Prostate Cancer Bone Metastases

  • Cynthia Lilieholm,
  • Adedamola O. Adeniyi,
  • Ohyun Kwon,
  • Jen Zaborek and ,
  • Caroline P. Kerr,
  • Hansel Comas Rojas,
  • Malick Bio Idrissou,
  • Carolina A. Ferreira,
  • Paul A. Clark and
  • Jamey P. Weichert
  • + 11 authors+ 6 authors

Rationale: Radium-223 dichloride (223RaCl2) is an FDA-approved alpha-emitting radiopharmaceutical that targets bone metastases in metastatic castration-resistant prostate cancer (mCRPC). This study investigates the therapeutic and immunological effec...

  • Article
  • Open Access
1 Citations
2,094 Views
11 Pages

Lymphocyte Function at Baseline Could Be a New Predictor of Tumor Burden following Six Cycles of Radium-223 Therapy in Patients with Metastasized, Castration-Resistant Prostate Cancer

  • Vahé Barsegian,
  • Daniel Möckel,
  • Sebastian Buehler,
  • Stefan P. Müller and ,
  • Michael C. Kreissl,
  • Patrick Ostheim,
  • Peter A. Horn and
  • Monika Lindemann
  • + 3 authors+ 0 author

22 February 2024

Previous data indicate that one cycle of treatment with radium-223 (223Ra) did not significantly impair lymphocyte function in patients with metastasized, castration-resistant prostate cancer. The aim of the current study was to assess in 21 patients...

(This article belongs to the Section Tumor Microenvironment)
  • Article
  • Open Access
16 Citations
4,381 Views
13 Pages

Nanomicelles of Radium Dichloride [223Ra]RaCl2 Co-Loaded with Radioactive Gold [198Au]Au Nanoparticles for Targeted Alpha–Beta Radionuclide Therapy of Osteosarcoma

  • Bárbara Nayane Rosário Fernandes Souza,
  • Elisabete Regina Fernandes Ramos Ribeiro,
  • Aline Oliveira da Silva de Barros,
  • Martha Sahylí Ortega Pijeira and ,
  • Hericka Oliveira Kenup-Hernandes,
  • Eduardo Ricci-Junior,
  • Joel Félix Silva Diniz Filho,
  • Clenilton Costa dos Santos,
  • Luciana Magalhães Rebelo Alencar and
  • Ralph Santos-Oliveira
  • + 7 authors+ 2 authors

30 March 2022

Alpha and beta particulate radiation are used for non-treated neoplasia, due to their ability to reach and remain in tumor sites. Radium-223 (223Ra), an alpha emitter, promotes localized cytotoxic effects, while radioactive gold (198Au), beta-type en...

(This article belongs to the Special Issue Polymers for Biomedical Imaging and Therapy)
  • Article
  • Open Access
30 Citations
3,719 Views
16 Pages

The Prognostic Role of Baseline Metabolic Tumor Burden and Systemic Inflammation Biomarkers in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Radium-223: A Proof of Concept Study

  • Matteo Bauckneht,
  • Sara Elena Rebuzzi,
  • Alessio Signori,
  • Maria Isabella Donegani and ,
  • Veronica Murianni,
  • Alberto Miceli,
  • Roberto Borea,
  • Stefano Raffa,
  • Alessandra Damassi and
  • Giuseppe Fornarini
  • + 12 authors+ 7 authors

31 October 2020

Over the last years has emerged the urgent need for the identification of reliable prognostic biomarkers able to potentially identify metastatic castration-resistant prostate cancer (mCRPC) patients most likely to benefit from Radium-223 (Ra-223) sin...

(This article belongs to the Special Issue Recent Scientific Developments in Metastatic Prostate Cancer)
  • Article
  • Open Access
13 Citations
3,345 Views
11 Pages

uPAR PET/CT for Prognostication and Response Assessment in Patients with Metastatic Castration-Resistant Prostate Cancer Undergoing Radium-223 Therapy: A Prospective Phase II Study

  • Marie Øbro Fosbøl,
  • Jann Mortensen,
  • Peter Meidahl Petersen,
  • Annika Loft and ,
  • Jacob Madsen and
  • Andreas Kjaer
  • + 1 author+ 0 author

The aim of this Phase II study was to investigate the potential for response assessment and prognostication of positron emission tomography (PET) using the ligand 68Ga-NOTA-AE105 targeting the urokinase-type plasminogen activator receptor (uPAR) in p...

(This article belongs to the Section Medical Imaging and Theranostics)
  • Article
  • Open Access
16 Citations
4,004 Views
13 Pages

Assessing Therapeutic Response to Radium-223 with an Automated Bone Scan Index among Metastatic Castration-Resistant Prostate Cancer Patients: Data from Patients in the J-RAP-BSI Trial

  • Kazuhiro Kitajima,
  • Junpei Kuyama,
  • Takashi Kawahara,
  • Tsuyoshi Suga and ,
  • Tomoaki Otani,
  • Shigeyasu Sugawara,
  • Yumiko Kono,
  • Yukihisa Tamaki,
  • Ayumi Seko-Nitta and
  • Koichiro Yamakado
  • + 14 authors+ 9 authors

16 May 2023

To evaluate the usefulness of change in the automated bone scan index (aBSI) value derived from bone scintigraphy findings as an imaging biomarker for the assessment of treatment response and survival prediction in metastatic castration-resistant pro...

(This article belongs to the Section Cancer Therapy)
  • Article
  • Open Access
16 Citations
3,231 Views
11 Pages

Prognostic Value of the BIO-Ra Score in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Radium-223 after the European Medicines Agency Restricted Use: Secondary Investigations of the Multicentric BIO-Ra Study

  • Matteo Bauckneht,
  • Sara Elena Rebuzzi,
  • Marta Ponzano,
  • Roberto Borea and ,
  • Alessio Signori,
  • Viviana Frantellizzi,
  • Elisa Lodi Rizzini,
  • Manlio Mascia,
  • Valentina Lavelli and
  • Giuseppe Fornarini
  • + 25 authors+ 20 authors

29 March 2022

The multicentric retrospective BIO-Ra study combined inflammatory indices from peripheral blood and clinical factors in a composite prognostic score for metastatic castration-resistant prostate cancer patients receiving Radium-223 (Ra-223). In the pr...

(This article belongs to the Special Issue PET/CT in Prostate Cancer)
  • Article
  • Open Access
35 Citations
4,605 Views
14 Pages

Role of Baseline and Post-Therapy 18F-FDG PET in the Prognostic Stratification of Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Treated with Radium-223

  • Matteo Bauckneht,
  • Selene Capitanio,
  • Maria Isabella Donegani,
  • Elisa Zanardi and ,
  • Alberto Miceli,
  • Roberto Murialdo,
  • Stefano Raffa,
  • Laura Tomasello,
  • Martina Vitti and
  • Silvia Morbelli
  • + 13 authors+ 8 authors

20 December 2019

Radium-223 dichloride (Ra223) represents the unique bone-directed treatment option that shows an improvement in overall survival (OS) in metastatic castrate resistant prostate cancer (mCRPC). However, there is an urgent need for the identification of...

(This article belongs to the Special Issue Role of Medical Imaging in Cancers)
  • Article
  • Open Access
3 Citations
2,666 Views
9 Pages

Tritium Labeling and Phase Distribution of 18-Crown-6 and Its Derivatives for Further Reprocessing of Radium Waste

  • Andrey G. Kazakov,
  • Taisya Y. Ekatova,
  • Julia S. Babenya,
  • Sergey E. Vinokurov and
  • Gennady A. Badun

20 September 2022

To date, the world has accumulated a large amount of long-lived radioactive materials that need to be disposed of or reprocessed. Such materials include nuclear legacy objects containing 226Ra, which is an important material for obtaining a wide rang...

(This article belongs to the Section A: Sustainable Energy)
  • Communication
  • Open Access
4 Citations
3,637 Views
12 Pages

Radium has been commonly used as a tracer of submarine groundwater discharge to the ocean and embankments, as radium activities are commonly input into box models to calculate a groundwater flux. Similarly, isotopes of radium (Ra224, Ra223, Ra226, Ra...

(This article belongs to the Section Marine Environment and Hydrology Interactions)
  • Article
  • Open Access
15 Citations
4,638 Views
17 Pages

Improved Formulation of 224Ra-Labeled Calcium Carbonate Microparticles by Surface Layer Encapsulation and Addition of EDTMP

  • Ruth Gong Li,
  • Kim Lindland,
  • Sandra Karen Tonstad,
  • Tina Bjørnlund Bønsdorff and ,
  • Asta Juzeniene,
  • Sara Westrøm and
  • Roy Hartvig Larsen
  • + 2 authors+ 0 author

Radium-224-labeled CaCO3 microparticles have been developed to treat peritoneal carcinomatosis. The microparticles function as carriers of 224Ra, facilitating intraperitoneal retention of the alpha-emitting radionuclide. It was necessary to control t...

  • Article
  • Open Access
45 Citations
6,047 Views
16 Pages

Recent Insights in Barium-131 as a Diagnostic Match for Radium-223: Cyclotron Production, Separation, Radiolabeling, and Imaging

  • Falco Reissig,
  • David Bauer,
  • Martin Ullrich,
  • Martin Kreller and ,
  • Jens Pietzsch,
  • Constantin Mamat,
  • Klaus Kopka,
  • Hans-Jürgen Pietzsch and
  • Martin Walther
  • + 4 authors+ 0 author

25 September 2020

Barium-131 is a single photon emission computed tomography (SPECT)-compatible radionuclide for nuclear medicine and a promising diagnostic match for radium-223/-224. Herein, we report on the sufficient production route 133Cs(p,3n)131Ba by using 27.5...

(This article belongs to the Section Radiopharmaceutical Sciences)
  • Feature Paper
  • Article
  • Open Access
40 Citations
5,252 Views
20 Pages

Trastuzumab Modified Barium Ferrite Magnetic Nanoparticles Labeled with Radium-223: A New Potential Radiobioconjugate for Alpha Radioimmunotherapy

  • Weronika Gawęda,
  • Marek Pruszyński,
  • Edyta Cędrowska,
  • Magdalena Rodak and ,
  • Agnieszka Majkowska-Pilip,
  • Damian Gaweł,
  • Frank Bruchertseifer,
  • Alfred Morgenstern and
  • Aleksander Bilewicz
  • + 4 authors+ 0 author

20 October 2020

Barium ferrite nanoparticles (BaFeNPs) were investigated as vehicles for 223Ra radionuclide in targeted α-therapy. BaFe nanoparticles were labeled using a hydrothermal Ba2+ cations replacement by 223Ra with yield reaching 61.3 ± 1.8%. Ra...

(This article belongs to the Special Issue Isotopes Labeled Nanoparticles)
  • Article
  • Open Access
22 Citations
6,186 Views
11 Pages

Safety and Efficacy of 177Lutetium-PSMA-617 Radioligand Therapy Shortly after Failing 223Radium-Dichloride

  • Justus Baumgarten,
  • Daniel Groener,
  • Christina Nguyen Ngoc,
  • Nicolai Mader and ,
  • Maximilian Chaurasia,
  • Karen Davis,
  • Jennifer Wichert,
  • Felix K. H. Chun,
  • Nikolaos Tselis and
  • Amir Sabet
  • + 7 authors+ 2 authors

22 January 2022

Bone-seeking 223Radium-dichloride (223Ra) is an established treatment prolonging survival and reducing morbidity in selected patients with metastatic castration-resistant prostate cancer (mCRPC) with skeletal involvement. Radioligand therapy with 177...

(This article belongs to the Special Issue Prostate-Specific Membrane Antigen (PSMA))
  • Article
  • Open Access
1 Citations
853 Views
25 Pages

2 June 2026

Radium and barium are hazardous contaminants that frequently occur in wastewater, posing significant risks to human health and the environment. This study provides a comparative evaluation of five synthetic zeolites—3A, 4A, 5A, 13X (commercial)...

(This article belongs to the Special Issue Adsorptive and Catalytic Materials Used in Environmental Treatment)
  • Article
  • Open Access
18 Citations
3,635 Views
20 Pages

Intercomparison of Radon Flux Monitors at Low and at High Radium Content Areas under Field Conditions

  • Daniel Rábago,
  • Luis Quindós,
  • Arturo Vargas,
  • Carlos Sainz and ,
  • Ileana Radulescu,
  • Mihail-Razvan Ioan,
  • Francesco Cardellini,
  • Marco Capogni,
  • Alessandro Rizzo and
  • Claudia Grossi
  • + 9 authors+ 4 authors

Interlaboratory exercises are a good tool to compare the response of different systems to the same quantity and to identify possible inconsistencies between them. One of the main goals of the EMPIR 19ENV01 traceRadon project is to harmonize radon flu...

(This article belongs to the Special Issue Indoor Radon Risk Assessment and Remedial Actions)

of 7